Sparrow Pharmaceuticals, Inc
Sparrow Pharmaceuticals, Inc., based in Portland, OR, is a clinical-stage biopharmaceutical company focused on developing targeted therapies for cardiometabolic conditions, particularly type 2 diabetes. Their lead candidate, clofutriben, is a highly potent HSD-1 inhibitor aimed at reducing elevated intracellular cortisol levels, which are linked to impaired glucose control in many patients with diabetes.
The company's innovative approach addresses the underlying causes of metabolic dysfunction by aiming to improve glycemic control and overall metabolic health for patients underserved by existing treatment options. With ongoing collaborations and clinical studies, Sparrow Pharmaceuticals is committed to advancing therapeutics that can make a meaningful impact on patients' lives.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.




